SOURCE: LaVoie Group

LaVoie Group

July 26, 2011 16:15 ET

Leah Monteiro Joins LaVoie Group Team as Senior Account Executive

Agency Expands Talent in Corporate Communications & Investor Relations

SALEM, MA--(Marketwire - Jul 26, 2011) - LaVoie Group, the acknowledged leader in life sciences and pharmaceutical communications, today announced the appointment of Leah Monteiro, Senior Account Executive. She joins the agency as a member of the client account teams, managing corporate communications, public relations and investor programs for the agency's life science and pharmaceutical clients.

Ms. Monteiro joins the LaVoie Group from the leading biotechnology company in the rare disease area, Genzyme Corporation, where she spent six years in roles of increasing responsibility in corporate communications and investor relations. While at Genzyme, most recently as Senior Manager, Leah was one of two corporate spokespeople responsible for interacting with the investment community, seeing the company through a manufacturing crisis, proxy fight, unsolicited bid and its eventual acquisition by Sanofi.

Monteiro also brings to LaVoie Group's clients experience in event planning, investor outreach and financial media relations, along with skills in the development of corporate and marketing materials. Previously in her career, she educated expectant families about the science of umbilical cord blood banking as a sales representative at ViaCord (now part of Perkin-Elmer). Leah began her career in hospital administration at Children's Hospital Boston before moving into corporate communications roles at CombinatoRx (now Zalicus) and TKT (now Shire).

"This is an exceptionally exciting time for many of our clients, several of which are on the verge of major transformations at their companies," said Donna LaVoie, President and Chief Executive Officer of LaVoie Group. "Leah's personality, core values, communications experience and knowledge of the life science and pharmaceutical industry are already a valuable asset to our clients and we are delighted to welcome her to our team at LaVoie Group."

"What attracted me to LaVoie Group was the depth of experience and knowledge in the pharmaceutical and life sciences industry, as well as the agency's approach to integrated communications in a rapidly changing regulatory, financial and industry environment," stated Monteiro. "I intend to apply my communications skills and experience and add a fresh perspective to the team as well as the value I bring to our clients."

About LaVoie Group
LaVoie Group partners with leading life sciences brands to build their companies, attract capital, and reach key stakeholders through integrated communications programs. We provide senior-level counsel to our clients, create visibility, and develop strategies and implementation tactics for corporate and/or product programs on a global scale.

Our clients are industry leaders in life sciences and pharmaceuticals such as Pfizer Inc., sanofi, Aegerion Pharmaceuticals, Alphatec Spine, Invida Group, Vertex Pharmaceuticals, Hepregen Corporation and Geneius. LaVoie Group is ranked by O'Dwyer's PR Report as one of the leading independent healthcare PR firms in the U.S. and has been honored by the LACP as "Boutique Agency of the Year" three years in a row, from 2008 to 2010. For more information, please visit: http://www.lavoiegroup.com.

Contact Information